SCHEMBL22471609

SCHEMBL22471609

Brc1ccc2c(c1)CCC21CCOCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.39
BACE1 P56817 3/20 0.37
APP P05067 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
BLM P54132 1/20 0.37
PNMT P11086 1/20 0.36
ASIC3 Q9UHC3 1/20 0.36
SLC18A3 Q16572 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
KCNH2 Q12809 1/20 0.34
TDP2 O95551 1/20 0.33
PARP1 P09874 1/20 0.33
PIK3CA P42336 1/20 0.32
CMA1 P23946 1/20 0.32
AHR P35869 1/20 0.32
METAP1 P53582 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5635261 0.87 KDM1A (0.44) KDM1ABACE1APPPNMTASIC3
SCHEMBL13769243 0.82 KDM1A (0.41) KDM1ABACE1APPPNMTASIC3
SCHEMBL2258656 0.81 TDP2 (0.41) KDM1ABACE1APPPNMTASIC3
SCHEMBL29067338 0.79 PNMT (0.47) KDM1ABACE1PNMTASIC3SLC18A3
SCHEMBL23671537 0.79 MAPT (0.36) BACE1LMNAMAPTBLMSIGMAR1
SCHEMBL449187 0.78 TDP1 (0.46) KDM1ABACE1APPSIGMAR1DRD2
SCHEMBL30508203 0.75 DRD2 (0.37) KDM1ABACE1SLC18A3SIGMAR1DRD2
SCHEMBL19567076 0.75 BACE1 (0.48) KDM1ABACE1APPLMNAMAPT
SCHEMBL5538070 0.74 KDM1A (0.39) KDM1ABACE1APPPNMTASIC3
SCHEMBL5531246 0.74 KDM1A (0.39) KDM1ABACE1APPPNMTASIC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3950682-B1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN) 2026-02-11 EP disclosed
US-12473298-B2 Amide compounds, preparation method therefor, and use thereof in the medical field SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD. (CN) 2025-11-18 US disclosed
CN-113330008-B Preparation method of amide compound and application of amide compound in medicine field 上海华汇拓医药科技有限公司 2024-05-07 CN disclosed
CN-117120419-A KLK5 bicyclic heteroaromatic inhibitors 拜奥克里斯特制药公司 2023-11-24 CN disclosed
EP-3950682-A1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD Shanghai Synergy Pharmaceutical Sciences Co., Ltd (CN) 2022-02-09 EP disclosed
US-20220024941-A1 Preparation Method for Amide Compounds and Use Thereof in Medical Field SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD. (CN) 2022-01-27 US disclosed
CN-113330008-A Preparation method of amide compound and application of amide compound in field of medicine 上海华汇拓医药科技有限公司 2021-08-31 CN disclosed
WO-2020192652-A1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD 上海华汇拓医药科技有限公司 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024941-A1 Preparation Method for Amide Compounds and Use Thereof in Medical Field EZH2, EZH1, IKZF2 KDM1A 40/4885BACE1 4504/4885APP 4520/4885
US-12473298-B2 Amide compounds, preparation method therefor, and use thereof in the medical field EZH2, IKZF2, EZH1 KDM1A 83/4885BACE1 3988/4885APP 4648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.